BAM
STJ

Bruderman Asset Management’s St Jude Medical STJ Stock Holding History

Bruderman Asset Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed – – 364
2016
Q4 		$0 Hold
1
– – ﹤0.01% 400
2016
Q3 		$0 Hold
1
– – ﹤0.01% 407
2016
Q2 		$0 Sell
1
-555
-100% -$39.6K ﹤0.01% 405
2016
Q1 		$31K Sell
556
-41
-7% -$2.23K 0.01% 238
2015
Q4 		$37K Hold
597
– – 0.01% 238
2015
Q3 		$38K Hold
597
– – 0.02% 232
2015
Q2 		$44K Hold
597
– – 0.02% 233
2015
Q1 		$39K Buy
+597
New +$39.7K 0.02% 240

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Bruderman Asset Management's STJ Position: Q1 2017 in Review

Bruderman Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1 share.

Bruderman Asset Management first reported a position in STJ in Q1 2015 and held it in 8 quarters. The position peaked at $44K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Bruderman Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Bruderman Asset Management sold 1 St Jude Medical share in Q1 2017.
  • Bruderman Asset Management first reported a position in St Jude Medical in Q1 2015 and held it in 8 quarters.
  • Bruderman Asset Management's St Jude Medical position peaked at $44K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bruderman Asset Management's 13F filing for Q1 2017, filed 9 May 2017.